Literature DB >> 15690689

[Role of apoptosis and chronic prostatitis in the pathogenesis of benign prostatic hyperplasia].

Bohdan Pawlicki1, Henryk Zieliński, Marek Dabrowski.   

Abstract

Benign prostatic hyperplasia (BPH) is the most common hyperplastic disease in aging male. The prostatic hyperplasia results from imbalance of immunoneuroendocrine homeostasis in which a paracrine activity of growth factors plays a substantial role. The mechanisms of BPH are multifactorial and are not yet recognized in the all details. Cell growth in the normal prostate is regulated by a delicate balance between cell death and cell proliferation. Disruption of the molecular mechanisms that regulate these processes may underline the abnormal growth of the prostate. On the basis of literature we have reviewed the role of endocrine environment, growth factors, intracellular proteins, pharmacological agents, microelements and particular role of the chronic prostatitis in the development of benign prostatic hyperplasia.

Entities:  

Mesh:

Year:  2004        PMID: 15690689

Source DB:  PubMed          Journal:  Pol Merkur Lekarski        ISSN: 1426-9686


  10 in total

1.  Modulatory effect of silymarin on inflammatory mediators in experimentally induced benign prostatic hyperplasia: emphasis on PTEN, HIF-1α, and NF-κB.

Authors:  Reem T Atawia; Hala H Mosli; Mariane G Tadros; Amani E Khalifa; Hisham A Mosli; Ashraf B Abdel-Naim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-08-28       Impact factor: 3.000

2.  Musulju improves benign prostatic hyperplasia by regulating inflammatory and apoptotic proteins.

Authors:  Jae-Yun Ju; Kyung-Sook Chung; Se-Yun Cheon; Hyo-Jin An
Journal:  Mol Med Rep       Date:  2016-10-12       Impact factor: 2.952

3.  2-Methoxyestradiol Attenuates Testosterone-Induced Benign Prostate Hyperplasia in Rats through Inhibition of HIF-1α/TGF-β/Smad2 Axis.

Authors:  Ashraf B Abdel-Naim; Thikryat Neamatallah; Basma G Eid; Ahmed Esmat; Abdulmohsin J Alamoudi; Gamal S Abd El-Aziz; Osama M Ashour
Journal:  Oxid Med Cell Longev       Date:  2018-08-01       Impact factor: 6.543

4.  Traditional Chinese medicine on treating chronic prostatitis/chronic pelvic pain syndrome: A systematic review and meta-analysis.

Authors:  Yahui Xue; Yunyun Duan; Xiaoyong Gong; Wei Zheng; Yongqiang Li
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

5.  Effectiveness comparisons of acupuncture for chronic prostatitis/chronic pelvic pain syndrome: A Bayesian network meta-analysis protocol.

Authors:  Yi Lei; Xueyun He; Jingshang Wang; Xiaoyong Gong; Wei Zheng; Yahui Xue; Yongqiang Li; Bao Zhang; Jiajia Ma; Chaohui Xue
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

6.  Cordycepin Attenuates Testosterone-Induced Benign Prostatic Hyperplasia in Rats via Modulation of AMPK and AKT Activation.

Authors:  Abdulmohsin J Alamoudi; Sami A Alessi; Waleed Y Rizg; Abdulmajeed M Jali; Awaji Y Safhi; Fahad Y Sabei; Sameer Alshehri; Khaled M Hosny; Ashraf B Abdel-Naim
Journal:  Pharmaceutics       Date:  2022-08-08       Impact factor: 6.525

7.  6-Paradol Alleviates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by Inhibiting AKT/mTOR Axis.

Authors:  Lenah S Binmahfouz; Haifa Almukadi; Abdulmohsin J Alamoudi; Ali M El-Halawany; Hossam M Abdallah; Mardi M Algandaby; Gamal A Mohamed; Sabrin R M Ibrahim; Faraj A Alghamdi; Majed Al-Shaeri; Ashraf B Abdel-Naim
Journal:  Plants (Basel)       Date:  2022-10-03

8.  Eriochloa villosa Alleviates Progression of Benign Prostatic Hyperplasia in vitro and in vivo.

Authors:  Eun Bok Baek; Youn-Hwan Hwang; Suyoung Park; Eun-Ju Hong; Young-Suk Won; Hyo-Jung Kwun
Journal:  Res Rep Urol       Date:  2022-09-24

9.  A phytosterol-enriched saw palmetto supercritical CO2 extract ameliorates testosterone-induced benign prostatic hyperplasia by regulating the inflammatory and apoptotic proteins in a rat model.

Authors:  Heggar V Sudeep; Karempudi Venkatakrishna; Ballal Amrutharaj; Kodimule Shyamprasad
Journal:  BMC Complement Altern Med       Date:  2019-10-17       Impact factor: 3.659

10.  Acupuncture combined with tamsulosin hydrochloride sustained-release capsule in the treatment of chronic prostatitis/chronic pelvic pain syndrome: A study protocol for a randomized controlled trial.

Authors:  Ji-Sheng Wang; Jie Yang; Sheng Deng; Xu-Dong Yu; Bing-Hao Bao; Rui-Jia Liu; Hai-Song Li
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.